Conformis CEO: Getting A Knee Up (Mad Money, CNBC)
Conformis is not responsible for the contents or reliability of any third-party materials accessible on Conformis’s website, including embedded videos, audio recordings and images, or links to external websites or other third-party materials. The information contained in such third-party materials may not be accurate or current, and Conformis does not necessarily endorse the views expressed within them. Any third-party materials are provided for your convenience and information only.
Conformis Announces Settlement of Patent Dispute with Smith & Nephew
Conformis to Receive $10.5 Million for Non-Exclusive License to Patient-Specific Instrument Patents for use with off-the-shelf knee implants BILLERICA, Mass.,
Conformis announces election of Carrie Bienkowski to its Board of Directors
BILLERICA, Mass., August 2, 2018 (GLOBE NEWSWIRE) – Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit